Instadose Pharma Corp. (OTCPK: INSD)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Instadose Pharma Corp. (OTCPK: INSD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $532.00 and employs 2 people.
trading between 0.00 and 0.00.
INSD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $532.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -735.72
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 531.93M
- Employees
- 2
- Next earnings
- —
About Instadose Pharma Corp.
Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.
- ISIN
- US45783B1035
- Founded
- 2017
- Listed since
- Oct 27, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,234.00 | +0.03% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.18 | +0.01% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.90 | -0.35% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.50 | -0.25% |
Figures last refreshed Aug 18, 2026.